Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
AstraZeneca
Pharma
Gilead's Trodelvy stumbles in first-line NSCLC
Despite Trodelvy's flop, analysts remain hopeful that Merck's rival TROP2 ADC, sac-TMT, can succeed in the same first-line NSCLC setting.
Angus Liu
Jun 9, 2026 11:14am
AstraZeneca reprimanded over LinkedIn likes once again
Jun 9, 2026 6:16am
Lilly, Boehringer slash investment plans in Germany
Jun 3, 2026 3:10pm
AZ's Imfinzi, Imjudo combo polishes case in early liver cancer
Jun 1, 2026 8:24am
AZ gains on Merck with 2nd bladder cancer nod for Imfinzi
May 28, 2026 4:39pm
Fierce Biotech
FDA delays ruling on AstraZeneca drug after negative adcomm vote
May 27, 2026 4:43am
